Logotype for KALA BIO Inc

KALA BIO (KALA) investor relations material

KALA BIO Proxy Filing summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for KALA BIO Inc
Proxy Filing summary19 Dec, 2025

Executive summary

  • The annual meeting is scheduled for January 30, 2026, and will be held virtually to enhance shareholder participation globally.

  • Shareholders of record as of December 30, 2025, are eligible to vote on key proposals, including director elections, executive compensation, auditor ratification, share issuances, amendments to the certificate of incorporation, and potential adjournment.

  • The board recommends voting in favor of all proposals, which are designed to support capital structure flexibility, compliance with Nasdaq requirements, and corporate governance best practices.

Voting matters and shareholder proposals

  • Seven proposals are up for vote: election of three Class II directors, advisory vote on executive compensation, ratification of HTL International, LLC as auditor, approval of share issuance upon preferred stock conversion, increase in authorized shares, reverse stock split, and adjournment if needed.

  • Approval of share issuance and increase in authorized shares are linked to recent financing and balance sheet restructuring, including a $6 million preferred equity investment and loan settlement.

  • Reverse stock split proposal allows the board to select a ratio between 1-for-2 and 1-for-100 to maintain Nasdaq listing and manage capital structure.

  • Shareholders may submit proposals for the 2026 annual meeting by specified deadlines and procedures.

Board of directors and corporate governance

  • The board consists of seven members divided into three classes with staggered three-year terms; independence is maintained per Nasdaq rules.

  • David Lazar serves as CEO, CFO, and Chair; Andrew Koven is Lead Independent Director.

  • Committees include audit, compensation, and nominating/governance, each with defined charters and independent membership.

  • The board held eight meetings in 2024, with all directors attending at least 75% of meetings.

  • Director nomination emphasizes integrity, business acumen, and diversity of skills and backgrounds.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next KALA BIO earnings date

Logotype for KALA BIO Inc
Q4 202527 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next KALA BIO earnings date

Logotype for KALA BIO Inc
Q4 202527 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

KALA BIO Inc. (formerly Kala Pharmaceuticals Inc.) is a biopharmaceutical company focused on developing and commercializing innovative treatments for ocular diseases. The company leverages its proprietary AMPPLIFY drug delivery technology, which enhances the penetration of therapeutic agents into target tissues. KALA BIO’s product portfolio includes treatments for conditions such as dry eye disease, ocular inflammation, and other front-of-the-eye disorders. The company is headquartered in Arlington, Massachusetts, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage